-
Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial -
Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
-
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
-
FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
-
Weight-Loss Jab Wegovy Available for the First Time on NHS
-
Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
-
Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
